Tuesday, October 9, 2018

Marina Biotech (MRNA) changes name to Adhera Therapeutics (ATRX)

Marina Biotech Announces Name Change to Adhera Therapeutics to More Closely Reflect the Mission of Improving Patient Outcomes
   
Research Triangle Park, NC, October 9, 2018 — Marina Biotech, Inc. (OTCQB: MRNA)), a commercial stage pharmaceutical company focused on the development and commercialization of innovative therapeutics for hypertension, arthritis and pain, today announced that it has changed its name to Adhera Therapeutics, Inc. and that it will begin using the ticker ATRX, in each case effective October 9, 2018. This new name reflects the company’s mission to develop and commercialize unique pharmaceutical therapies and leverage technology to improve patient outcomes.

Posted by at
Labels: , , ,

No comments:

Post a Comment

Subscribe to: Post Comments (Atom)